Life Sciences M&A Activity Signals Strategic Shift Toward Larger, High-Stakes Deals

Share!

Risk & Insurance - Jan 29, 2026

Despite declining transaction volume in 2024, life sciences companies are pursuing bigger acquisitions to secure drug portfolios, integrate AI capabilities, and navigate the looming patent cliff. The post Life Sciences M&A Activity Signals Strategic Shift Toward Larger, High-Stakes Deals appea...

Read Full Article

Recommended Articles

Insurers Face the Same Cyber Threats They Underwrite — and Gaps Remain

Posted: Apr 16, 2026

A joint report from the Insurance Information Institute and Fenix24 found that insurers, despite set...

Read Article

Jeff Green Discusses Innovation, Challenges and Leading the Charge in Public Risk Management

Posted: Apr 16, 2026

Jeff Green, the risk manager for Larimer County, Colo. Recounts his years in the profession and why...

Read Article

Psychological Safety on Jobsites Directly Reduces Incidents and Turnover, Analysis Shows

Posted: Apr 15, 2026

Poor communication contributes to nearly 70% of workplace incidents, underscoring the business case...

Read Article